ImmunotherapyCombined Modality TherapyCancer VaccinesMechlorethamineImmunotherapy, AdoptiveProcarbazineImmunotherapy, ActiveAntigens, NeoplasmNeoplasmsHodgkin DiseaseAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsLomustineRadiotherapyDesensitization, ImmunologicVincristineDendritic CellsT-Lymphocytes, CytotoxicRadiotherapy DosageClinical Trials as TopicMelanoma, ExperimentalPrednisoneActuarial AnalysisCell Line, TumorCarcinoma, Small CellSurvival AnalysisMelanomaT-LymphocytesNeoplasm StagingMice, Inbred C57BLCD8-Positive T-LymphocytesTreatment OutcomePrognosisAntibodies, MonoclonalHLA-A2 AntigenTumor EscapeSurvival RateLymphocytes, Tumor-InfiltratingRadiotherapy, AdjuvantNeoplasm ProteinsCytotoxicity, ImmunologicAdenocarcinomaCyclophosphamideHLA-A24 AntigenMonitoring, ImmunologicMice, Inbred BALB CProstatic NeoplasmsCisplatinLymphocyte ActivationNeoplasms, ExperimentalDisease-Free SurvivalChemotherapy, AdjuvantCarcinoma, Non-Small-Cell LungHLA-A AntigensEarly Detection of CancerColonic NeoplasmsFollow-Up StudiesNeoplasm TransplantationFluorouracilInterferon-gammaAntigen PresentationAntineoplastic AgentsAntibodies, NeoplasmEpitopes, T-LymphocyteFlow CytometryOvarian NeoplasmsNeoplasm MetastasisTumor MicroenvironmentInterleukin-2DoxorubicinInjections, IntralesionalBreast NeoplasmsTumor Cells, CulturedVaccines, SubunitGenetic TherapyCTLA-4 AntigenMice, TransgenicAdministration, SublingualAdjuvants, ImmunologicCD4-Positive T-LymphocytesT-Lymphocytes, Regulatorygp100 Melanoma AntigenCytokine-Induced Killer CellsSublingual ImmunotherapyGene Expression Regulation, NeoplasticGenetic VectorsMolecular Targeted TherapyMice, NudeKiller Cells, NaturalImmunization, PassiveMelanoma-Specific AntigensImmunologic SurveillanceRhinitis, Allergic, SeasonalReverse Transcriptase Polymerase Chain ReactionSkin NeoplasmsMice, SCIDCongresses as TopicMART-1 AntigenImmune ToleranceVaccines, DNA